IGEN BIOTECH GROUP is working in new approaches to Medicine, discovering a variety of biological activities from vegetal and animal sources, which entail a major potential in terms of therapy and preventive diagnosis. IGEN BIOLAB, as part of Igen Biotech Group works on the specific development of a functional protein profile for oncological and degenerative diseases. IGEN BIOLAB specializes in protein production, bacterial characterization and development of manufacturing processes that are optimized for robust high scale up production. Our R&D facilities include technical areas of In vitro cultivation and testing of microorganisms, mass spectrometry-based proteomics technologies to identify, characterize and quantify target proteins in various biological and biomedical samples, metabolomics for detection and quantification of small molecules (metabolites) in biological materials, microbiomics focusing on using molecular DNA microarray technology to address the complexities of human infections and environmental microbiome ecology. Our commitment is to develop functional protein immunotherapies that help physicians and other healthcare professionals to provide high quality medical nutrition care and to improve patients’ quality of life.